Market Access Sponsored NCVR: What's the true price of negotiation? A country’s ability to open trials quickly is a key consideration for commercial sponsors planning programmes of research globally.
Patients From participants to partners: The evolution of active patie... Recruitment numbers are the backbone of clinical research.
R&D Sponsored Revolutionising research: Inside the NCVR evolution in the U... On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
Patients Conducting successful commercial research in a primary care ... The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends